Cybin Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
CYBN NYSE American 2834 www.cybin.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cybin Inc.

Psychedelic: Compass, GH Research, MindMed report quarterly earnings - May 9th, 2025 3:11 pm
Cybin Announces Additional U.S. Patent Supporting its CYB003 Breakthrough Therapy Program in Phase 3 Development for Major Depressive Disorder - May 8th, 2025 11:30 am
Cybin to Participate at the 28th Annual Milken Institute Global Conference - May 1st, 2025 11:30 am
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Apr 27th, 2025 7:31 pm
Psychedelic: Clearmind completes clinical site initiations for AUD trial - Apr 25th, 2025 3:30 pm
Cybin Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Phase 3 Program Evaluating CYB003 - Apr 23rd, 2025 11:30 am
Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs - Apr 21st, 2025 12:00 pm
Psychedelic: Exclusive talk with biotech company Clearmind Medicine - Mar 22nd, 2025 2:30 pm
Psychedelic: atai Life Sciences, NRx report quarterly results - Mar 21st, 2025 3:50 pm
Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial - Mar 14th, 2025 3:40 pm
Cybin Inc. (CYBN) Loses -25.81% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Mar 4th, 2025 2:35 pm
Psychedelic: GH Research, Compass Pathways report earnings results - Feb 28th, 2025 4:30 pm
Wall Street Analysts Think Cybin Inc. (CYBN) Could Surge 988.67%: Read This Before Placing a Bet - Feb 17th, 2025 2:55 pm
Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights - Feb 11th, 2025 2:48 am
Wall Street Analysts Believe Cybin Inc. (CYBN) Could Rally 952.23%: Here's is How to Trade - Jan 30th, 2025 2:55 pm
Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder - Jan 15th, 2025 5:07 pm
Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025 - Jan 13th, 2025 12:30 pm
Cybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - Jan 9th, 2025 10:00 pm
Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including CYB003 12-Month Efficacy Results - Dec 10th, 2024 12:30 pm
Cybin to Participate in Water Tower Research Fireside Chat on December 11, 2024 - Dec 4th, 2024 12:30 pm